Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How about 1 ActiPatch over each lung 24/7 for a month?????
Or placed over each lung 24/7 on someone diagnosed with COVID-19 for a month????
Summary - The “coronavirus disease 2019” (“COVID-19”) epidemic, like other similar epidemics before it, requires careful attention and consideration of various preventive measures including routinely recommended public health measures and other more aggressive measures. Similar measures can be reasonably applied for other types of respiratory viral infections commonly seen in the winter. Such measures should be strongly considered especially for those most vulnerable. These aggressive measures include starting or increasing the daily intake of vitamin D3 at the level of at least 10,000 IU per day and initiating or continuing higher intensity PEMF therapies daily to the whole body and/or to the lungs. This therapy can be administered at home.
https://www.drpawluk.com/blog/coronavirus-pemf-and-vitamin-d3/
Remember, Viagra was discovered and developed serendipitously by Pfizer, because a heart medication did good things for men taking the heart medication!
Here's what I want to happen, right now.
Have Dr. Sree Koneru and Dr. Richard Staelin get in a car and take a 6-Pack of Actipatches to the CDC in Atlanta.
Ask to be shown a petrie dish full of cultured and growing COVID-19 virus. Prove that the virus is alive and well and replicating. Put the petrie dish inside an 8' Protector XStream Laboratory Fume Hood, turn on an ActiPatch and place the patch around the petrie dish.
Now observe what 1,000 pulses per second does to that virus. I don't know that it will inhibit cellular replication of the virus or create a necrotic state within the virus in the petrie dish, in any way, but I also do not know that 1,000cps of PEMF from the ActiPatch won't accomplish those results, until I see the results.
We know that ActiPatch stimulates healing at the cellular or molecular level. The one thing I know for sure is I don't know, so why not try it? Because, if it does in any way inhibit cellular replication of the virus or create a necrotic state, oh baby! Many issues in the pharma and medical spaces are resolved through serendipity, oh baby!
Takes a big man to draft and post that statement. I nominate Jimzin for the BoD of BIEL on his character and as Master Distiller and executive at Covington Vodka and Target Marketing.
Current CEO just needs to let Keith Nalepka make deals and get rid of the former CEO name toxicity and fix the insane share structure. Looking at it in reverse order - if she takes the bold move of 'disappearing' billions of shares, by boldly lowering family holdings, would that not scream loudly there is nothing toxic about HER? The current CEO can easily circle shareholder wagons to protect against adverse power plays, not an issue!
Let's try reversing my pleas. If the current CEO would boldly fix the share debacle, she would show shareholders, detractors and the world, that she is her own person and a leader willing to fix the problems from the past, not the blame and her name, in two parts, incidentally, would rise in lustre and be viewed with respect.
People would not believe it, if they knew who first suggested the family simply 'disappear' shares. The guy was brilliant in the simplicity of his suggestion.Kudos to that man, brilliant sir!
I've said for almost a year, fix the toxic name and share issues, first 1, then 2. Didn't see the possibility that fixing the 2nd issue first goes a long way in fixing the first, the toxic name issue. Seems so simple, looking at it now in reverse order and would make the current CEO a hero in shareholders eyes, no?
"Dr Scholls was a deal cancelled after a redesign of our one approved product, that's been MIA for two years off the shelf."
Something I have been wondering about since the former CEO said, "No" to any deal with Dr. Scholls because they wanted to do their own manufacturing, under license. They have the $$$ and management skillset to do it, before breakfast, but the former CEO needed to be in charge of everything, a patternalistic thing . . .
Was a deal of some kind done on the foot product, we were not informed of? Was it shelved forever for cash? I would like the questions asked about it to be clearly answered and to know that it too can be taken to market!
"Dr Scholls was a deal cancelled after a redesign of our one approved product, that's been MIA for two years off the shelf."
Something I have been wondering about since the former CEO said, "No" to any deal with Dr. Scholls because they wanted to do their own manufacturing, under license. They have the $$$ and management skillset to do it, before breakfast, but the former CEO nerd to be in charge of everything, a paternalistic thing . . .
Was a deal of some kind done on the foot product, we were not informed of? Was it shelved forever for cash? I would like the questions asked about it to be clearly answered and to know that it too can be taken to market!
My whole point in post 218787.
By fixing the outrageous share structure issue first...does that management move not resolve the red flags of the toxic former CEO name issue?
Would that move alone not remove all similar thinking to, "Management is the same in a younger version. We have to overcome the carryover baggage. Perception is what we are victims of, nothing more." This is how people view it.
I think it's a smart way for the current CEO to be very much respected and seen as a competent leader in the pharma/pain space. Things that have been totally missing for at least 12 years.
BIEL management would no longer be laughed at or criticized at all levels. Question now of course is, does the current CEO have the smarts and courage to make the leadership moves and get it done? Time will tell and there may be little time. It would take a week.
As was said to the former CEO many, many, many times, by many, many people "Stop trying to hit a home run on your first deal. Make your first deal, make it for small markup over your costs, but get it rolling. When the first deal comes in, others will soon follow."
The response? "No, I want $30 million, the average FDA clearance costs $30 million, that's my price.'
"That's absurd, you don't have $30 million in this."
"But, that's what the average FDA clearance costs, so that should be the price."
I knew who he was negotiating with, because he told me and asked me to keep quiet about it.
I repeated, "Make the deal, if you don't, you will regret it and add years more of no revenue and living hand to mouth, and off he would go on another tangent about how the big deal was just around the next corner.
So yes, get the first deal done and in the house. The rest will come.
"You do realize a double-play is not a good thing in baseball when comparing to a single?
Two run homer would be better."
In business, a double-play is a truly wonderful thing and far better than a single. I don't want any home runs. I want steady, solid, responsible management of the ActiPatch opportunity. Keith Nalepka on the front-end making a great deal or great deals and the BIEL team backing him up by delivering what they must to take BIEL out of its 12 year toilet, originated by the former CEO.
Earlier - "Now, if she would only fix the still present toxic former CEO name issue and the outrageous share structure, then, when a large deal is announced, the stock will fly."
Kelly Whelan and the BIEL team are the team backing up Keith Nalepka's sales efforts - they must deliver!
"In response to the thought that timing is everything, and that you want to stimulate the SP, IF they were to have an announcement, I would think that it would be better to wait and see if the Market can stabilize a little instead of these wild swings. Then release the news, some are basically still in the sell mood until it calms down."
Where you suggest 'an announcement', what if there might be a double announcement? I recall the disclosure that there were 3 NDA's. Personally, I doubted that disclosure, but what if? Keith Nalepka is very experienced in the pharma and pain spaces, would a double-play not be better than a single? Ex-pro ball player and all?
Earlier - "Now, if she would only fix the still present toxic former CEO name issue and the outrageous share structure, then, when a large deal is announced, the stock will fly."
Change that to my wondering about a double-play - Now, if she would only fix the still present toxic former CEO name issue and the outrageous share structure, then, when a large deal OR DEALS ARE announced, the stock will fly."
Does anyone know the status of the disclosed 3 NDA opportunities? I'm not speculating here, I am simply wondering.
I know someone told Kelly Whelan that tweeting her true feelings and thoughts was just hurting herself, more than a few times, and that someone was only trying to help her! As an observer, I'm glad she paid attention - much more professional and dignified!
Now, if she would only fix the still present toxic former CEO name issue and the outrageous share structure, then, when a large deal is announced, the stock will fly.
Good post - smart.
Anticipated news from last Monday/Tuesday?
Projected huge sales from the VA?
Projected huge sales from B Braun?
Projected huge sales from Mundi?
Projected huge sales from all those foreign countries, not requiring the reinstatement of the CE Mark?
CE Mark pushed out (May), deals taking longer than expected.
The current share structure.
Red flag former CEO toxic name still in BIEL.
Deferred sales $536K?
I can't see the implementation of basic turnaround steps 101.
My nose is still twitching hard that something is up.
Soon . . . ?
Too funny for words . . . . can't do much except shake head.
MIA . . .
Anticipated news from last Monday/Tuesday?
Projected huge sales from the VA?
Projected huge sales from B Braun?
Projected huge sales from Mundi?
Projected huge sales from all those foreign countries, not requiring the reinstatement of the CE Mark?
CE Mark pushed out (May), deals taking longer than expected.
The current share structure.
Red flag former CEO toxic name still in BIEL.
Deferred sales $536K?
I can't see the implementation of turnaround steps 101.
My nose is still twitching hard that something is up.
Would it offend anyone, if I said, soon . . . ?
Please read again, I did not imply she was complicit at all!
Thank you PT. . . .
"Thank you Simps!
But I'm not sure if I would go as far as to say KW is a victim, I was thinking complicit.
She lacked the courage to do the right thing when her father was alive, and seem to lack it still!
Or maybe it's not a lack of courage, maybe it's just a stubbornness to do things her way, irregardless as to whether it's the right way, similar to her father."
I'll cut her a lot of slack - no question the former CEO was a very complicated guy and life in the Whelan draconian milieu was certainly very difficult for employees, suppliers, customers and shareholders, so it could not have been easy in familial relationships. Enough said. Part of me liked the guy, mostly I just shook my head in amazement for many years.
The current CEO knows the issues, knows the tremendous opportunity to enhance the shareholder potential by implementing a couple of turnaround steps, so it's entirely up to her inner courage and character to do the right things or not and to be accountable for her decisions. Far easier to do the right things, in this case I would suggest, rather than living with the legacy described in the last paragraph. . . . . soon
Put briefly, there are 10 ways of retaining control, if the Whelans reduced their holdings to say 7 billion of 34 billion shares total, by 'disappearing' 28 billion of 62. On the 100 million, maybe add a zero, then start wondering.
Again, worth his weight in gold. I would be astounded if it's not 750 or more. 500 plus monies owed, remember, the former CEO owed employees a ton.
100 million shares makes absolutely no sense. That's about $80,000., less than 2 weeks work for small successful turnaround firms onboarding 2 people. No, Keith Nalepka is worth his weight in gold, if he can turn the previous sales debacle around and deliver a deal or two this quarter, like now!
The critical keys then become toxic former CEO name red flags and Whelans using intelligence in rectifying the share structure by 'disappearing at least 28 billion of their existing and convertible note potential shares. Tick tock. . . .soon.
He could see clearly the downward spiral of the former CEO, confidence in his own skillset, sales experience, his vision of the potential impact for shareholders and chronic and acute pain sufferers of the brilliant device, ActiPatch, pride and personal ROI. Same reasons many stayed in despite the huge red flags of name toxicity, share structure, former CEO self-dealing and deal fatigue. Enough?
It's coming together, but I don't think Q4 LY was anything more than BIEL coming out of toilet hibernation, after 10-12 years of abject misery, starting on October 7th, when the current CEO assumed the crown.
Can anyone intelligently define material management actions taken since then to launch BIEL forward? Like getting the toxic red flag name of the former CEO out of the profile? Fixing the absurd share structure? No and no. Putting Keith Nalepka on the BoD was a start. Releasing him and his team to make deals, maybe, hopefully!
Anything else? No, and reinstating the CE Mark doesn't remotely qualify, it's only fixing part of the absurd former cluster. And, who really cares, it's the US market that is the mother lode. Nope, it's Q1 that is the harbinger of positivity for all shareholders.
Toxic name, fix share structure, deals, 1, 2, 3. Could all happen in less than a week, if the current CEO is wise, courageous and nimble. Share price would fly and BIEL would have the management team of the century!
Pharma and business media would go insane in their tributes. Certainly nothing is ever accomplished through arguing, screaming, colored text or Caps. Intelligence and timing rule. What a timing opportunity. Paradise or continue the struggle.
Great post....intelligent, insightful, the truth.
"In a way they acknowledge that he was reckless by seeking partnership deals with the same companies he turned down, and yet no one comes out and actually says it, KW prefers to direct her anger at shareholders instead!"
The acknowledgement, as to the former CEO, is obvious, through thundeting silence. It is very difficult and very delicate. I've said many times, the current CEO was a victim, had to be! And because of DNA, almost inescapable, DNA, love, sadness, manipulation!
Does she know? Of course, very intelligent. If/when she shucks off the baggage from the past, common sense should prevail. Can she? Time will tell, but there is a significant time crunch requiring courage, decisiveness and action.
She has 100's of million$ and her freedom, as a person, to gain by implementing the management suggestions made and much to lose or never gain, by not! Time will tell. Tick tock . . .soon.
I suggest again, respectfully, that my strong sense that something is up is using the same faculties that wondered why the deferred sales of $536K and going after the truth of the bungled, expired CE Mark as the truth behind the deferred sales.
And the same faculties that sensed a cluster with Dr. Scholl's, and CVS, and KT Tape, and went after the truth of the former cluster CEO having said "No" to them all, as the truth behind why Keith Nalepka was thwarted in his efforts to make those deals.
And the same faculties the became very concerned in 2016 about the advancing aging issues of the former CEO.
I still say, I sense something is up and if it's deals, then BIEL must be in the best shape the help any upside in share price run higher and with greater sustainability. And that means getting the toxic name of the former CEO and his misdeeds the hell out of the way and fixing the absurd share structure first!
If management stupidity, procrastination and inertia obviate fixing those two turnaround components, then I suggest any sp run will not be as long or strong coming out of the 12 year toilet the former CEO put us in after the 12.9 cent run of 08 and 09. And if the Whelans reduce their holdings from 35 billion to 7 billion, they will hold the same value at $.0045 with 7 billion, as they do now at $.0009 holding 35 billion shares.
Ask yourself this. Does a company with 62 billion shares run longer and stronger than a company with 34 billion? Or does it struggle to run because of the stupid share structure and run out of gas? If the probability favors 'No', it will likely struggle, then the reason the Whelans should move quickly to correct the share structure is valid.
Run long and hard vs staying closer to the toilet works for all shareholders. The significance of the triple play must not be overlooked. Fixing the absurd share structure, first. Taking that innovative step, then getting the former CEO's toxic name and his red flags out of the way, also first, followed by a great deal or two will put BIEL in the right sp range it so deserves - patented, miracle, miniaturized, drug-free, side-effect free pain device.
Really? And ActiPatch was going to receive general FDA clearance in 2008, 09, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19. Sought legal counsel. Really? NDA's. Really?
Let's agree that Keith Nalepka and his sales staff will deliver the bacon, shall we? Soon.
Intelligent tactical management does not rely on polls.
MANY TENS OF BILLIONS of shares is the honesty of the BIEL share structure and why it must be fixed, as prescribed, with the Whelans 'disappearing' 28 Billion of their shares and getting their red flag name under the radar the former CEO caused. That way all shareholders, mostly the Whalens, can realize the share potential.
You bet it is and the best part is the last word!
All irrelevant nonsense.
I have a better course to add to the Wharton MBA program. The negative influences on Market Capitalization values and rising share prices of historical red flags on management and oppressive share structures.
BIEL would be a perfect case study candidate. Management red flags involving former CEO name highly toxic residue, check. Oppressive share structure, check. Patented products, check. Disruptive technology, check. Nepotism, check. Resistence to mmediately remediate corporate issues, check. Urgency, immediate. Major SWOT Threat, $200 Million. Strategic & tactical timing, soon, very soon.
Prognosis if remediation not completed before major business transactions announced. Biggest management blunder involving unecessarily constrained shareholder value imaginable. Put the course under strategic and tactical opportunity management. Soon. . . .
Complex issues art2426. Age, not so much. Health and idiosyncrasies. Thing is if the current CEO does what's very much needed, the intelligent steps proven to be critical in 100's of turnarounds, the Whelan family will do extraordinarily well. If not, then they will not do as well. You know what happened leading to the resignations of BIEL Directors in late 2016, Dr. Staelin and Mary Whelan, the former CEO's defiance of recommendations by Physicians, etc., etc., etc. It's a cluster history! He paid a huge price by totalling ignoring the sound advice of many others, including that of the current CEO! Other than that, who cares?
My sense is that we have a situation of DNA. Not her fault. Former CEO belligerent mantra was "I'll do what I want!" Same guy who told CVS, Dr. Scholl's and KT Tape - "No!", while people had advised him to just make the first deal, even if it's not very fat, make it! He was always the smartest guy in the room and it got worse as his aging issues worsened. Everyone else was stupid! Sad.
I've laid out the incredible potential upside for the Whelan family and all shareholders. We will see.
“That leaves, in order of priority, the critical toxicity in the pain space of the Former/current CEO name, the outrageous share structure and the management bungle on the CE Mark. The CE Mark is an operational issue and will get done and I assume everyone is accepting of the fact that there is zero business with B. Braun to be concerned about and that it never launched. So, the company is left struggling against the negative forces of the name toxicity - you don't have to do much DD to see that.
The share structure is equally critical, but the current CEO can't seem to grasp that the Whelan family controlling 35 billion shares at .0008 has the same value as 7 billion at .0045 and by disappearing 28 billion shares will enable the sp to run farther and faster once deals are announced. And a CPA to boot. So, it's either hiding something, narcissism, a defiance disorder, stupid greed or some other issue best not raised here. No one is that dumb, there must be a reason, who would deliberately do that to themselves?"
217899 . . . "If she could 'get' that 35 billion shares @ $ .0009 is worth $31.5 Million and so are 7 billion shares @ $.0045, that would be a good thing. And, IF, the likelihood of the sp running into the realm of 5 cents is increased if the OS are 35 Billion instead of the current 62 billion with all notes redeemed, that would also be a good thing. So by 'disappearing 28 billion of the Whelan 35 Billion, there is an increase in the potential!”
My sense is we will be okay - I just wish the current CEO would get rid of the toxic name issue handed down to her by the former CEO, SEC, etc., and fix the obscene share structure, as suggested. If those two issues were resolved, yesterday, then BIEL will have a much, much higher probability of running into pennyland, when deals are announced, rather than struggling and grinding to the .008 range coming out of the 10 year toilet.
Nonsense, utter nonsense
The bare bones theory of the mathematics of market cap are basically accurate. It just lacks inclusion of all potential eventualities, IBEX, St. John's, unconverted loan instruments, and the sophistication gleaned in 4th year undergrad and grad school found in tactics and strategies.
Apologies. . . . typo... should be $.0045, as posted many times
There is another wind change speakhim . . . see 217768 . . .
"We are in roughly the same camp. I don't "think" there are deals on the table, I am convinced something is up, as I detect an almost imperceptible change in the winds of communication coming out of BIEL, in source, quantity and tenor. The wind change is there!
That leaves, in order of priority, the critical toxicity in the pain space of the Former/current CEO name, the outrageous share structure and the management bungle on the CE Mark. The CE Mark is an operational issue and will get done and I assume everyone is accepting of the fact that there is zero business with B. Braun to be concerned about and that it never launched. So, the company is left struggling against the negative forces of the name toxicity - you don't have to do much DD to see that.
The share structure is equally critical, but the current CEO can't seem to grasp that the Whelan family controlling 35 billion shares at .0008 has the same value as 7 billion at .0045 and by disappearing 28 billion shares will enable the sp to run farther and faster once deals are announced. And a CPA to boot. So, it's either hiding something, narcissism, a defiance disorder, stupid greed or some other issue best not raised here. No one is that dumb, there must be a reason, who would deliberately do that to themselves?"
217899 . . . "If she could 'get' that 35 billion shares @ $ .0009 is worth $31.5 Million and so are 7 billion shares @ $.0045, that would be a good thing. And, IF, the likelihood of the sp running into the realm of 5 cents is increased if the OS are 35 Billion instead of the current 62 billion with all notes redeemed, that would also be a good thing. So by 'disappearing 28 billion of the Whelan 35 Billion, there is an increase in the potential!
Removing the name toxicity is much simpler, just google BioElectronics for the evidence of that. Major focus of any turnaround is to determine what red flags there may be and remove them ASAP. These are the major red flags and both are easy to eradicate. That would be astute management and proof that prior DNA does not necessarily dictate current management actions. How refreshing that would be for shareholders and liberating for her! As I said, it's not all her fault, at all, she was a victim too. Highly complex and highly sensitive, but the truth!"
Hmmmm - she had better implement resolutions for the toxic name and outrageous share issues BEFORE any “announcement”, so all shareholders, mostly the Whelans, can benefit from the incredible upside potential if the issues are managed properly, compared to a mediocre rise, if they are not.
There is another wind change speakhim . . . see 217768 . . .
"We are in roughly the same camp. I don't "think" there are deals on the table, I am convinced something is up, as I detect an almost imperceptible change in the winds of communication coming out of BIEL, in source, quantity and tenor. The wind change is there!
That leaves, in order of priority, the critical toxicity in the pain space of the Former/current CEO name, the outrageous share structure and the management bungle on the CE Mark. The CE Mark is an operational issue and will get done and I assume everyone is accepting of the fact that there is zero business with B. Braun to be concerned about and that it never launched. So, the company is left struggling against the negative forces of the name toxicity - you don't have to do much DD to see that.
The share structure is equally critical, but the current CEO can't seem to grasp that the Whelan family controlling 35 billion shares at .0008 has the same value as 7 billion at .0045 and by disappearing 28 billion shares will enable the sp to run farther and faster once deals are announced. And a CPA to boot. So, it's either hiding something, narcissism, a defiance disorder, stupid greed or some other issue best not raised here. No one is that dumb, there must be a reason, who would deliberately do that to themselves?"
217899 . . . "If she could 'get' that 35 billion shares @ $ .0009 is worth $31.5 Million and so are 7 billion shares @ $.0009, that would be a good thing. And, IF, the likelihood of the sp running into the realm of 5 cents is increased if the OS are 35 Billion instead of the current 62 billion with all notes redeemed, that would also be a good thing. So by 'disappearing 28 billion of the Whelan 35 Billion, there is an increase in the potential!
Removing the name toxicity is much simpler, just google BioElectronics for the evidence of that. Major focus of any turnaround is to determine what red flags there may be and remove them ASAP. These are the major red flags and both are easy to eradicate. That would be astute management and proof that prior DNA does not necessarily dictate current management actions. How refreshing that would be for shareholders and liberating for her! As I said, it's not all her fault, at all, she was a victim too. Highly complex and highly sensitive, but the truth!"
Hmmmm - she had better implement resolutions for the toxic name and outrageous share issues BEFORE any “announcement”, so all shareholders, mostly the Whelans, can benefit from the incredible upside potential if the issues are managed properly, compared to a mediocre rise, if they are not.
Thank you - I have always seen this as potentially a major restrictive issue.
Quote: "after 14 years of mismanagement by the former CEO, that will impede the sp from running to the appropriate price"
Imagine if the current CEO would become extremely open-minded and internalize and agree that she was also a victim, all those years, of the former CEO management style? That her state of wealth is a direct result?
If she could 'get' that 35 billion shares @ $ .0009 is worth $31.5 Million and so are 7 billion shares @ $.0009, that would be a good thing. And, IF, the likelihood of the sp running into the realm of 5 cents is increased if the OS are 35 Billion instead of the current 62 billion with all notes redeemed, that would also be a good thing. So by 'disappearing 28 billion of the Whelan 35 Billion, there is an increase in the potential!
Removing the name toxicity is much simpler, just google BioElectronics for the evidence of that. Major focus of any turnaround is to determine what red flags there may be and remove them ASAP. These are the major red flags and both are easy to eradicate. That would be astute management and proof that prior DNA does not necessarily dictate current management actions. How refreshing that would be for shareholders and liberating for her! As I said, it's not all her fault, at all, she was a victim too. Highly complex and highly sensitive, but the truth!
Not necessarily "retire".....it's how the turnaround transition is done. No substitute for 'smoothly'.
She could appoint one of her attorneys as a Director. Even appoint 4 out of 7 so she maintains control in her camp. But get the toxic name out of there, it's a huge red flag for anyone doing even amateur level DD. Elect Dr. Richard Staelin back onto the board, yesterday.
Then fix the stupid share structure. 35 billion shares at .0008 is the same value as 7 billion at .0045! Restructuring the board, fixing the share structure and 2 deals takes the stock way north, so who cares? By not doing all 3 steps, the stock may still languish in the toilet created by the former CEO. Take the personal and familial crap out of it, it's business! Main thing is do these things to help yourselves and the company, rather than continuing to do nothing to complete a much-needed turnaround.
The former/current CEOs and the toxicity of their family name and presence, SEC, charges, convictions, fines and barments from any involvement in penny stock shares, etc.;
The bungled CE Mark; and
The outrageous share structure, are the best sales force that all of BIEL's competitors could ever have.
The entire hot and cold pack and Tens pain sectors and the pain drug boys have already gone around and passed BIEL and they are all praying that Kelly Whelan does not find common sense and take the sound advice she now has. See my previous posts.
The BIEL sales team is fighting the negative forces of it's own CEO in getting BIEL and its shareholders to where they should be.
Getting deals done is no longer an issue with me, they will happen, the sales team is that good! The problem is the total absence of completing other critical elements of the required BIEL turnaround, after 14 years of mismanagement by the former CEO, that will impede the sp from running to the appropriate price.
It's the cumulative effect of all the turnaround elements that will take BIEL into the pennies. Get past the DNA!
"I have a different take. I think there are deals on the table. I think they take more time than most want to wait. Some will choose not to believe this and play armchair CEO. Some will believe there are deals and move forward in faith that the technology is real, the team is competent and that there is a keen interest by multiple companies at this very moment. I’m in the latter camp."
We are in roughly the same camp. I don't "think" there are deals on the table, I am convinced something is up, as I detect an almost imperceptible change in the winds of communication coming out of BIEL, in source, quantity and tenor. The wind change is there!
That leaves, in order of priority, the critical toxicity in the pain space of the Former/current CEO name, the outrageous share structure and the management bungle on the CE Mark. The CE Mark is an operational issue and will get done and I assume everyone is accepting of the fact that there is zero business with B. Braun to be concerned about and that it never launched. So, the company is left struggling against the negative forces of the name toxicity - you don't have to do much DD to see that.
The share structure is equally critical, but the current CEO can't seem to grasp that the Whelan family controlling 35 billion shares at .0008 has the same value as 7 billion at .0045 and by disappearing 28 billion shares will enable the sp to run farther and faster once deals are announced. And a CPA to boot. So, it's either hiding something, narcissism, a defiance disorder, stupid greed or some other issue best not raised here. No one is that dumb, there must be a reason, who would deliberately do that to themselves?
There is no legal position preventing correcting the absurd share structure and there are a dozen ways to protect the mother lode. No one has made any kind of move against the Whelans and no one would.
A LA is not the way to go, more costly for the company and its shareholders.
The key issues are the toxicity of the former and current CEO names and the share structure. The CE Mark issue gets resolved as an operations solution and has no effect on BD and sales in the USA.
Keith Nalepka and Erin are a great team and will get the deals, guaranteed, but correcting the other two issues will IMO assure much greater wealth once the deals come in. Imagine your holdings today, at .0008, are worth what your adjusted holdings will be worth at .0045. What would you do?
Imagine the BIEL sp grinding its way up to .006 to .008 under the double burden of the former/current CEOs name toxicity and 62 billion shares. Or running to north of 5 cents with a cleaner house and a lighter share structure of 34 billion shares. 35 billion shares @ .0009 is the same as 7 billion shares @ .0045! 'Disappear' the 28 billion shares and 'Disappear' the toxic name and get ready for the deals and pennyland, rather than languishing in the toilet. Make sense? Of course it makes sense.
"Day 140. Starting from October 15th."
Hedging the 180? Current CEO 'assumed' the vacated mantle October 7 - 180 days is around April 3rd, no?
How much time does anyone over the age of 6 need to see that the name toxicity from the former CEO and the SEC enforcement proceedings, fines and barments and the stupid share structure are the main items keeping BIEL in the .000 toilet? Don't believe me? Google BioElectronics!
Keith Nalepka and the sales team will deliver deals, high competency there, but get working on the former/current CEO negative name association issues and the share structure.
Stay in the triple/double zero land, .000 and .00, through defiance, (NO!!!!, I'll show you!!!!, I'll do it myself!!!, all shareholders are stupid!!!, everyone is stupid, FDA, customers, suppliers, lawyers, employees, everyone!!!) or, run to centsville, 3 cents, 5 cents 8 cents. Common sense! Deals are key, competent management is magic, something BIEL sadly did not have. It's time.
Not in a million years, make it 2 million.
Still deep in the toilet, .0007, because of (i)the toxicity the former CEO's (and current CEO's) name is still still involved and the SEC debacle;
(ii)no CE Mark;
(iii)no deals, but that issue will be resolved by VP Sales Keith Nalepka, and
(iv)the outrageous share structure. Solutions provided, no need to repeat them. Not complicated. Just require common sense and humility, two things sadly absent in former CEO.
The deals will come, without question, but the other 3 issues are the direct responsibility of the current CEO to remedy in anticipation of those deals. You would think she would resolve the other 3 issues without delay, so as to maximize the upside sp potential.
Imagine only sputtering up to, say, $.006 to .008, with one or two good deals in the house, thanks to the sales team, or watching BIEL as it runs to north of 5 cents because the current CEO managed effectively? Name toxicity, CE Mark and the moronic share structure. How long does it take? How about announce on Friday for the Whelan name toxicity and the share structure. Any more and it's self-destructive DNA at play! Tick tock . . .